Bill Commons

MA S 2035

in committee

An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

Massachusetts · 2025-2026 Regular Session (194th General Court) · upper

Description

By Mr. Lewis, a petition (accompanied by bill, Senate, No. 2035) of Jason M. Lewis and Rebecca L. Rausch for legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.

Introduced
—
Status date
—
Latest action
2026-07-23 — Accompanied a study order, see H5596
Bill type
bill
Last updated
—

Sponsors

  • Jason M. Lewisprimary
  • Rebecca L. Rauschcosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-02-27

    Referred to the committee on Revenue

    referral-committee

  2. 2025-02-27

    House concurred

  3. 2025-10-21

    Hearing scheduled for 10/28/2025 from 01:00 PM-05:00 PM in B-2

  4. 2026-04-01

    Reporting date extended to Thursday June 25, 2026

  5. 2026-07-23

    Accompanied a study order, see H5596

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

https://malegislature.gov/Bills/194/S2035

Attribution

Data from openstates_api_sync, retrieved 2026-07-24T11:44:01.997778Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=S 2035. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.